“The existing condition has uncovered some structural weaknesses while in the EU’s medicines provide chain and also a higher dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides claimed. She encouraged that offer chain troubles be dealt with in an EU pharmaceutical strategy envisioned for being launched by the end… Read More